Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic magnesium sulfate for prevention of hospital sepsis in preterm neonates with respiratory distress syndrome
IRCT20080901001162N28Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of magnesium sulfate in hospital-acquired sepsis (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Duration of assisted ventilation, Time to full oral feeding and 1 more. Started May 2024; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
hospital-acquired sepsis
Beyond the preview
Go deeper on IRCT20080901001162N28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20080901001162N28.